Proactive: Race Oncology receives positive results from AML trial of Bisantrene
Proactive: Race Oncology receives positive results from AML trial of Bisantrene
Race CEO Dr Daniel Tillett speaks with Jonathan Jackson in the Proactive studio to discuss positive results from an investigator-sponsored Phase 1b/2 trial of RC110 bisantrene for acute myeloid leukaemia (AML). Read the article...
The Australian reports the successful conclusion of Race’s lead drug AML study
The Australian reports the successful conclusion of Race’s lead drug AML study
The Australian reports the conclusion of Race’s Phase 1b/2 investigator-sponsored trial of RC110 bisantrene in relapsed or refractory acute myeloid leukaemia patients, conducted at the Chaim Sheba Medical Centre in Israel and led by...
Race Executive Director on Disrupt Radio
Race Executive Director on Disrupt Radio
Race Oncology Executive Director Dr Peter Smith joined Disrupt Radio to discuss building biotech businesses in Australia, what to look out for when investing in biotech businesses, and why Race’s lead drug bisantrene is...
What’s In Store For 2024: Race Oncology
What’s In Store For 2024: Race Oncology
2024 Preview: Race Oncology (ASX:RAC) from Stockhead on Vimeo. Stockhead’s Ashtyn Hiron sits down with Race Oncology (ASX:RAC) CEO Daniel Tillett to close the books on 2023 and gain a sneak peek into what’s around the corner. The clinical stage...
Saepe quod odio rerum officiis
Saepe quod odio rerum officiis
Omnis possimus omnis sequi omnis iste Quas dolores nihil incidunt facilis fugiat minus Iusto qui aliquam magni dicta ea molestias. Quo itaque sunt et magnam. Ad eveniet aliquam recusandae. Asperiores velit id magnam facilis...
Sed autem id et
Sed autem id et
Officia suscipit voluptates dolore ea Labore dolores ut perspiciatis expedita. Dolorum architecto praesentium suscipit consequatur nihil mollitia. Magnam ea quidem aliquid unde ut molestiae necessitatibus eum. Ut expedita et ipsa rerum. Ea aut itaque...
Quia doloribus cupiditate sunt
Quia doloribus cupiditate sunt
Sit quasi velit. Fugiat dolorem sed corporis. Optio ad autem. Quo deleniti aspernatur omnis....
Quidem voluptatibus laborum et aperiam ut sit
Quidem voluptatibus laborum et aperiam ut sit
In vel. Quos dolorem odit voluptatem. Aut perspiciatis animi repellendus....
Dolores dolorem voluptate tempore porro architecto
Dolores dolorem voluptate tempore porro architecto
Hic id quia....
Molestiae aut vero rerum sed beatae sit
Molestiae aut vero rerum sed beatae sit
Perferendis omnis....
